In addition, the relationship between clinicopathological features and PDIA6 expression levels in patients with endometrial cancer was shown in Table I, indicating a significant correlation between PDIA6 expression and FIGO stage and lymph node metastasis in patients with endometrial cancer. This evidence concerns the gene PDIA6 and metastatic malignant neoplasm in the lymph nodes.